Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
No filings held for this insider can be measured against the deadline.
The 10 most recent Form 4 transactions.
| KalVista Pharmaceuticals,… |
| DTOISS◆ |
| 10,000 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Jun 11 | KALV | KalVista Pharmaceuticals,… | DTOISS◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | KALV | KalVista Pharmaceuticals,… | DTOISS◆ | 7,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | KALV | KalVista Pharmaceuticals,… | DTOISS◆ | 7,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | KALV | KalVista Pharmaceuticals,… | DTOISS◆ | 7,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | KALV | KalVista Pharmaceuticals,… | DTOISS◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | KALV | KalVista Pharmaceuticals,… | DTOISS◆ | 6,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | KALV | KalVista Pharmaceuticals,… | DTOISS◆ | 12,000 | — | — | — | Open the original filing on SEC.gov |